Summary & Overview
HCPCS Level II Q4432: 510(k) Skin Substitute Product, Adjunct
HCPCS Level II code Q4432 identifies an FDA 510(k)-cleared skin substitute product supplied in addition to a primary procedure. The code matters nationally because skin substitutes are increasingly used in complex wound care and reconstructive procedures, and correct coding ensures appropriate product tracking and payer adjudication. This analysis covers common national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the code’s clinical context, expected sites of service, and typical use as an adjunct to primary surgical or wound procedures. The publication summarizes payer coverage patterns, billing considerations, and related billing benchmarks where available, and highlights policy updates that affect reimbursement and documentation requirements. The content aims to clarify when Q4432 is reported (as an additional line for the skin substitute product) and what clinical scenarios commonly involve skin substitute use, such as complex soft-tissue wounds, burns, and reconstructive grafting. Data not available in the input is noted explicitly where applicable.
Billing Code Overview
HCPCS Level II code Q4432 describes a 510(k) skin substitute product, not otherwise specified (list in addition to primary procedure). This code is used to identify a skin substitute product cleared via the FDA 510(k) pathway when it is supplied in addition to the primary surgical or wound care procedure.
-
Service type: Skin substitute product supply used as an adjunct to primary wound or surgical procedures
-
Typical site of service: Hospital operating room, outpatient surgical center, wound care clinic, or other procedural settings where a primary procedure is performed
Clinical & Coding Specifications
Clinical Context
A typical patient for code Q4432 is an adult with a full-thickness or complex partial-thickness wound (for example, a non-healing diabetic foot ulcer, venous stasis ulcer, or a traumatic soft-tissue defect) requiring application of a 510(k)-cleared skin substitute as an adjunct to wound care. The clinical workflow begins with wound assessment in an outpatient wound clinic, emergency department, or inpatient setting. Initial steps include history and physical, optimization of comorbid conditions (glycemic control, infection control, vascular assessment), wound bed preparation (debridement, hemostasis, control of bioburden), and measurement/photodocumentation. When the wound bed is clean and viable, the clinician selects a 510(k) skin substitute product not otherwise specified and documents product identity and quantity. The procedure typically involves local anesthesia or analgesia, application of the skin substitute to the prepared wound, securing with appropriate dressings, and instruction for follow-up wound care visits for dressing changes and reassessment. Typical sites of service include outpatient wound care clinics, hospital outpatient departments, physician offices, and inpatient acute care units when medically necessary.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |